ARTICLE | Company News
Hemosol receives Hemolink priority review
August 28, 2000 7:00 AM UTC
Canada granted priority review status to the NDS from Hemosol (TSE:HML) for Hemolink crosslinked hemoglobin 10 percent solution to reduce use of donor blood in coronary artery bypass graft ( CABG) sur...